E. Shinoda

发表

Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.

Takeshi Kimura, T. Morimoto, H. Shiomi, 2020, Circulation journal : official journal of the Japanese Circulation Society.

Effect of Heart Failure on Long‐Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Journal of the American Heart Association.

Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2

A. Kastrati, M. Nobuyoshi, M. Horie, 2015, PloS one.

Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy)

S. Hosoda, A. Hirayama, E. Shinoda, 2007, Journal of hypertension.

Surgical management of a giant atrial septal aneurysm

E. Shinoda, K. Minatoya, J. Nishizawa, 2021, Clinical case reports.

Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study

Takeshi Kimura, T. Morimoto, H. Shiomi, 2021, BMJ Open.

Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3).

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With versus Without Chronic Kidney Disease.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Demographics, practice patterns and long-term outcomes of patients with non–ST-segment elevation acute coronary syndrome in the past two decades: the CREDO-Kyoto Cohort-2 and Cohort-3

Takeshi Kimura, T. Morimoto, H. Shiomi, 2021, BMJ Open.

Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan　- From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Quantitative Coronary Angiogram Analysis: Nifedipine Retard Versus Angiotensin-Converting Enzyme Inhibitors (JMIC-B Side Arm Study)

S. Hosoda, A. Hirayama, E. Shinoda, 2005, Hypertension.

Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat.

S. Sasayama, E. Shinoda, T. Aoyama, 2000, Journal of molecular and cellular cardiology.

Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, Circulation journal : official journal of the Japanese Circulation Society.

Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat.

S. Sasayama, E. Shinoda, T. Aoyama, 2000, International journal of cardiology.

Surgical management of a giant atrial septal aneurysm

E. Shinoda, K. Minatoya, J. Nishizawa, 2020, Clinical case reports.

Tissue Factor Pathway Inhibitor-2 Is a Novel Mitogen for Vascular Smooth Muscle Cells*

S. Sasayama, E. Shinoda, T. Aoyama, 1999, The Journal of Biological Chemistry.

Concomitant Mitral Regurgitation in Severe Aortic Stenosis

M. Toyofuku, C. Izumi, Takeshi Kimura, 2021 .

Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent: Long-Term (5–7 Years) Follow-Up of the Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2

M. Nobuyoshi, M. Horie, R. Nohara, 2014, Circulation. Cardiovascular interventions.

Anemia in Patients with Severe Aortic Stenosis

M. Toyofuku, M. Onoe, C. Izumi, 2019, Scientific Reports.

Coronary Artery Disease Without Standard Cardiovascular Risk Factors.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2021, The American journal of cardiology.

Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization

M. Toyofuku, M. Onoe, Y. Kihara, 2022, JACC. Asia.

Effect of ebselen on bovine and rat nitric oxide synthase activity is modified by thiols.

S. Sasayama, E. Shinoda, T. Aoyama, 1996, Japanese journal of pharmacology.

Anemia in Patients with Severe Aortic Stenosis

M. Toyofuku, M. Onoe, C. Izumi, 2019, Scientific Reports.

Asymptomatic versus Symptomatic Patients with Severe Aortic Stenosis

M. Toyofuku, M. Onoe, Y. Hiraoka, 2018, Scientific Reports.

Sex Differences in Clinical Outcomes After Percutaneous Coronary Intervention.

M. Toyofuku, Takeshi Kimura, T. Morimoto, 2022, Circulation journal : official journal of the Japanese Circulation Society.

Concomitant Mitral Regurgitation in Severe Aortic Stenosis　- A Report From the CURRENT AS Registry.

M. Toyofuku, C. Izumi, Takeshi Kimura, 2021, Circulation journal : official journal of the Japanese Circulation Society.